Synchrotron radiation microtomography allows the analysis of three-dimensional microarchitecture and degree of mineralization of human iliac crest biopsy specimens: Effects of etidronate treatment

被引:130
作者
Nuzzo, S
Lafage-Proust, MH
Martin-Badosa, E
Boivin, G
Thomas, T
Alexandre, C
Peyrin, F [1 ]
机构
[1] European Synchrotron Radiat Facil, BP 220, F-38043 Grenoble, France
[2] INSA, CREATIS, Villeurbanne, France
[3] INSERM E9901, St Etienne, France
[4] Univ Barcelona, Dept Fis Aplicada Ptica, Lab Ptica, Barcelona, Spain
[5] INSERM, U403, Lyon 08, France
关键词
bone architecture; degree of mineralization of bone; osteoporosis; quantitative microtomography; etidronate;
D O I
10.1359/jbmr.2002.17.8.1372
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Quantitative microcomputed tomography using synchrotron radiation (SR muCT) was used to assess the effects of a sequential etidronate therapy on both three-dimensional (3D) microarchitecture and degree of mineralization of bone (DMB) in postmenopausal osteoporosis. Thirty-two iliac crest biopsy specimens were taken from 14 patients with osteoporosis (aged 64 +/- 1.8 years) before (baseline) and after I year of etidronate treatment, and after 2 years of treatment for four of the patients. The samples were imaged at high spatial resolution (voxel size = 10 mum), using the microtomography system developed at the European Synchrotron Radiation Facility (ESRF), Grenoble, France. Three-dimensional microarchitecture parameters were calculated and compared with those obtained from conventional histomorphometry. In addition, the DMB was evaluated also in 3D. No significant statistical changes regarding bone mass and structural parameters were observed in histomorphometry or 3D analyses. The distribution of the DMB in cortical and trabecular bone showed a trend to a shift toward highest mineralization values after I year of etidronate treatment (3.88% and 1.24% in cortical and trabecular bone, respectively). This trend was more evident after 2 years. The study also showed that SR muCT is an accurate technique and the only one for quantifying both the mineralization and the microarchitecture of bone samples at the same time in 3D.
引用
收藏
页码:1372 / 1382
页数:11
相关论文
共 55 条
[1]  
BALENA R, 1992, J BONE MINER RES, V7, pS328
[2]  
Barou O, 1999, J PHARMACOL EXP THER, V291, P321
[3]   Three-dimensional imaging of trabecular bone using the computer numerically controlled milling technique [J].
Beck, JD ;
Canfield, BL ;
Haddock, SM ;
Chen, TJH ;
Kothari, M ;
Keaveny, TM .
BONE, 1997, 21 (03) :281-287
[4]   Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures [J].
Black, DM ;
Cummings, SR ;
Karpf, DB ;
Cauley, JA ;
Thompson, DE ;
Nevitt, MC ;
Bauer, DC ;
Genant, HK ;
Haskell, WL ;
Marcus, R ;
Ott, SM ;
Torner, JC ;
Quandt, SA ;
Reiss, TF ;
Ensrud, KE .
LANCET, 1996, 348 (9041) :1535-1541
[5]  
BOIVIN G, 1984, METHODS CALCIFIED TI, P391
[6]   Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women [J].
Boivin, GY ;
Chavassieux, PM ;
Santora, AC ;
Yates, J ;
Meunier, PJ .
BONE, 2000, 27 (05) :687-694
[7]   3D COMPUTED X-RAY TOMOGRAPHY OF HUMAN CANCELLOUS BONE AT 8 MU-M SPATIAL AND 10(-4) ENERGY RESOLUTION [J].
BONSE, U ;
BUSCH, F ;
GUNNEWIG, O ;
BECKMANN, F ;
PAHL, R ;
DELLING, G ;
HAHN, M ;
GRAEFF, W .
BONE AND MINERAL, 1994, 25 (01) :25-38
[8]   Bone histomorphometric evaluation of pamidronate treatment in clinically manifest osteoporosis [J].
Bravenboer, N ;
Papapoulos, SE ;
Holzmann, P ;
Hamdy, NAT ;
Netelenbos, JC ;
Lips, P .
OSTEOPOROSIS INTERNATIONAL, 1999, 9 (06) :489-493
[9]   Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis [J].
Chavassieux, PM ;
Arlot, ME ;
Reda, C ;
Wei, L ;
Yates, AJ ;
Meunier, PJ .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (06) :1475-1480
[10]   Predicting subsequent bone density response to intermittent cyclical therapy with etidronate from initial density response in patients with osteoporosis [J].
Crilly, RG ;
Sebaldt, RJ ;
Hodsman, AB ;
Adachi, JD ;
Brown, JP ;
Goldsmith, CH ;
Hanley, DA ;
Olszynski, WO ;
Ste-Marie, LG ;
Stephenson, GF .
OSTEOPOROSIS INTERNATIONAL, 2000, 11 (07) :607-614